Efficacy of Disease Modifying Therapies in Progressive MS and How Immune Senescence May Explain Their Failure

The advent of disease modifying therapies (DMT) in the past two decades has been the cornerstone of successful clinical management of multiple sclerosis (MS). Despite the great strides made in reducing the relapse frequency and occurrence of new signal changes on neuroimaging in patients with relaps...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Navid Manouchehri, Victor H. Salinas, Negar Rabi Yeganeh, David Pitt, Rehana Z. Hussain, Olaf Stuve
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Frontiers Media S.A. 2022-03-01
Serie:	Frontiers in Neurology
Soggetti:	adaptive immunity innate immunity multiple sclerosis immunosenescence progressive multiple sclerosis disease modifying therapies
Accesso online:	https://www.frontiersin.org/articles/10.3389/fneur.2022.854390/full
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!